Wird geladen...
Tau immunotherapies: Lessons learned, current status and future considerations
The majority of clinical trials targeting the tau protein in Alzheimer’s disease and other tauopathies are tau immunotherapies. Because tau pathology correlates better with the degree of dementia than amyloid-β lesions, targeting tau is likely to be more effective in improving cognition than clearin...
Gespeichert in:
| Veröffentlicht in: | Neuropharmacology |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7492435/ https://ncbi.nlm.nih.gov/pubmed/32360477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2020.108104 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|